日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

辅助性帕博利珠单抗治疗与观察治疗肌层浸润性尿路上皮癌的比较

Apolo, Andrea B; Ballman, Karla V; Sonpavde, Guru; Berg, Stephanie; Kim, William Y; Parikh, Rahul; Teo, Min Yuen; Sweis, Randy F; Geynisman, Daniel M; Grivas, Petros; Chatta, Gurkamal; Reichert, Zachery Roger; Kim, Joseph W; Bilen, Mehmet Asim; McGregor, Bradley; Singh, Parminder; Tripathi, Abhishek; Cole, Suzanne; Simon, Nicholas; Niglio, Scot; Ley, Lisa; Cordes, Lisa; Srinivas, Sandy; Huang, Jiaoti; Odegaard, Meagan; Watt, Colleen; Petrylak, Daniel; Hoffman-Censits, Jeannie; Wen, Yujia; Hahn, Olwen; Mitchell, Cecilia; Tan, Alan; Streicher, Howard; Sharon, Elad; Moon, Helen; Woods, Michael; Halabi, Susan; Perez Burbano, Gabriela; Morris, Michael J; Rosenberg, Jonathan E

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

下一代保留膀胱围手术期治疗肌层浸润性膀胱癌患者的试验终点

Necchi, Andrea; Galsky, Matthew D; Dizman, Nazli; Aggen, David H; Agarwal, Neeraj; Al-Ahmadie, Hikmat; Apolo, Andrea B; Ballas, Leslie; Bangs, Rick; Black, Peter C; Brausi, Maurizio; Brembilla, Giorgio; Cheng, Liang; Chiti, Arturo; Cimadamore, Alessia; Colecchia, Maurizio; Daneshmand, Siamak; Di Stasi, Savino; Efstathiou, Jason A; Filicevas, Alex; Geynisman, Daniel M; Grivas, Petros; Gupta, Shilpa; Iasonos, Alexia; James, Nick D; Lerner, Seth P; Loriot, Yohann; Makaroff, Lydia E; Maluf, Fernando; Moschini, Marco; Ostrovnaya, Irina; Pal, Sumanta K; Plimack, Elizabeth R; Prakash, Gagan; Psutka, Sarah P; Rosenberg, Jonathan E; Sadeghi, Sarmad; Schmidt, Bogdana; Schwartz, Lawrence H; Sonpavde, Guru P; St Laurent, Marie-Pier; Ye, Dingwei; Spiess, Philippe E; Kamat, Ashish M

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023)

癌症临床试验中受试者的性能状态资格要求和入组特征,最终获得美国食品药品监督管理局 (FDA) 的药物批准(2009-2023 年)

Iannantuono, Giovanni Maria; Floudas, Charalampos S; Filetti, Marco; Giovagnoli, Tommaso; Sganga, Stefano; Vitale, Antonio; Chandran, Elias; Lombardi, Pasquale; Rosenfeld, Roberto; Giudice, Elena; Xue, Elisabetta; Rapisarda, Elvira; Troisi, Paola; Apolo, Andrea B; Karzai, Fatima; Bria, Emilio; Gulley, James L; Daniele, Gennaro

A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationale

一项评估sacituzumab govitecan联合或不联合atezolizumab治疗罕见泌尿生殖系统肿瘤的II期研究(SMART)——设计和原理

Kydd, Andre R; Chandran, Elias; Simon, Nicholas I; Atiq, Saad; Ley, Lisa; Wang, Tzu-Fang; Cordes, Lisa; Patel, Ruchi; Smith, Elizabeth; Boudjadi, Salah; Niglio, Scot A; Yousefi-Rad, Abbas; Weng, Sally; Stukes, Ian; Banday, A Rouf; Akbulut, Dilara; Gurram, Sandeep; Redd, Bernadette; Steinberg, Seth; Choo-Wosoba, Hyoyoung; Apolo, Andrea B

E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors-design and rationale

E-VIRTUE:一项评估恩福妥单抗联合或不联合帕博利珠单抗治疗罕见泌尿生殖系统肿瘤的研究——设计和原理

Chandran, Elias B A; Atiq, Saad; Simon, Nicholas; Girardi, Daniel; Ley, Lisa; Cordes, Lisa; Patel, Ruchi; Wang, Tzu-Fang; Kydd, Andre R; Redd, Bernadette; Boudjadi, Salah; Stukes, Ian; Banday, Rouf; Smith, Elizabeth; Akbulut, Dilara; Niglio, Scot; Gurram, Sandeep; Steinberg, Seth; Apolo, Andrea B

A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale

一项关于 lurbinectedin 联合或不联合 avelumab 治疗小细胞膀胱癌(激光治疗)的 II 期研究——设计和原理

Simon, Nicholas; Chandran, Elias; Atiq, Saad; Kydd, Andre R; Girardi, Daniel; Ley, Lisa; Cordes, Lisa; Wang, Tzu-Fang; Boudjadi, Salah; Stukes, Ian; Smith, Elizabeth; Akbulut, Dilara; Niglio, Scot; Patel, Ruchi; Banday, Rouf; Redd, Bernadette; Gurram, Sandeep; Steinberg, Seth; Apolo, Andrea B

Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma

CheckMate 9ER 中生活质量的简明语言总结:卡博替尼联合纳武利尤单抗治疗晚期肾细胞癌

Cella, David; Motzer, Robert J; Suarez, Cristina; Blum, Steven I; Ejzykowicz, Flavia; Hamilton, Melissa; Wallace, Joel F; Simsek, Burcin; Zhang, Joshua; Ivanescu, Cristina; Choueiri, Toni K; Apolo, Andrea B

Antibody-drug conjugates in rare genitourinary tumors: review and perspectives

抗体药物偶联物在罕见泌尿生殖系统肿瘤中的应用:综述与展望

Kydd, Andre R; Sarwar, Md Shahid; Atiq, Saad; Chelluri, Raju; Gurram, Sandeep; Chandran, Elias; Simon, Nicholas; Stukes, Ian; Weng, Sally; Yousefi-Rad, Abbas; Banday, A Rouf; Boudjadi, Salah; Apolo, Andrea B

Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer

在患有高级别 BCG 难治性非肌层浸润性膀胱癌的成人患者中,卡介苗 (BCG) 联合 PANVAC™ 与单独使用 BCG 的疗效比较

Ho, Matthew; Lazarovich, Alon; Saoud, Ragheed; Dahmen, Aaron; Tremblay, Samuel; Telfer, Siobhan; Maruf, Mahir; Singer, Eric A; Weiss, Robert E; Jang, Thomas L; Elsamra, Sammy E; Merino, Maria; Dolan, Rebecca; Valera, Vladimir; Rodriquez, Beatriz Walter; Railkar, Reema; Bellfield, Sonia; Stamatakis, Lambros; Shih, Joanna; Donahue, Renee N; Navarro, Cesar Pico; Apolo, Andrea B; Gulley, James L; Schlom, Jeffrey; Agarwal, Piyush K

Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials

高危肌层浸润性尿路上皮癌的辅助免疫疗法:随机临床试验的系统评价和荟萃分析

Oscar-Thompson, Laura; Riveros, Carlos; Sonpavde, Guru; Apolo, Andrea B; Lalani, Aly-Khan A; Wallis, Christopher J D; Satkunasivam, Raj